Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Date of authorisation: 16/07/2001, Revision: 21, Status: Authorised

List of eligible industry stakeholder organisations

EMA closed on Whit Monday, 25 May

Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - November 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 November 2026, 14:00 (CET) to 26 November 2026, 18:00 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2026, 09:00 (CEST) to 8 October 2026, 13:00 (CEST)

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Ryeqo, relugolix,estradiol,norethisterone acetate, Date of authorisation: 16/07/2021, Revision: 8, Status: Authorised

Data Analysis and Real World Interrogation Network (DARWIN EU)

Human medicines European public assessment report (EPAR): Mimpara, cinacalcet, Date of authorisation: 22/10/2004, Revision: 27, Status: Withdrawn